DRUG vs RMAX

Comparison between Bright Minds Biosciences Inc (DRUG, Company) and RE/MAX Holdings Inc - Class A (RMAX, Company).

DRUG is from the Healthcare sector, while RMAX is from the Real Estate sector.

5-Year PerformanceDRUG has outperformed RMAX, delivering a return of +27.0% compared to -21.5%

DRUG vs RMAX - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	DRUG(COMPANY)	RMAX(COMPANY)
Market Cap	$724M	$722M
Max Drawdown	97.68%	91.58%
Sharpe Ratio	1.67	0.32
5Y Beta	-0.76	1.09
Industry	Biotechnology	Real Estate Services
P/E Ratio	-30.67	31.40
Forward P/E	N/A	12.08
PEG Ratio	-0.08	4.07
5Y Dividends CAGR	N/A	3.68%
5Y EPS CAGR	8.42%	N/A
Debt to Equity	0.03%	97.72%
Free Cash Flow Yield	-2.01%	4.62%
P/S Ratio	N/A	1.96
P/B Ratio	3.49	0.51

Market Cap

Winner

DRUG

$724M

RMAX

$722M

Max Drawdown

DRUG

97.68%

Winner

RMAX

91.58%

Sharpe Ratio

Winner

DRUG

1.67

RMAX

0.32

5Y Beta

Winner

DRUG

-0.76

RMAX

1.09

Industry

DRUG

Biotechnology

RMAX

Real Estate Services

P/E Ratio

Winner

DRUG

-30.67

RMAX

31.40

Forward P/E

DRUG

N/A

RMAX

12.08

PEG Ratio

Winner

DRUG

-0.08

RMAX

4.07

5Y Dividends CAGR

DRUG

N/A

RMAX

3.68%

5Y EPS CAGR

DRUG

8.42%

RMAX

N/A

Debt to Equity

Winner

DRUG

0.03%

RMAX

97.72%

Free Cash Flow Yield

DRUG

-2.01%

Winner

RMAX

4.62%

P/S Ratio

DRUG

N/A

RMAX

1.96

P/B Ratio

DRUG

3.49

Winner

RMAX

0.51

DRUG vs RMAX - Historical Returns

Returns include dividend reinvestment.

Period	DRUG	RMAX
1 month	+9.46%	-5.52%
3 months	-19.61%	+41.01%
6 months	-18.06%	+16.21%
1 year	+138.59%	+6.81%
5 years(CAGR)	+26.98%	-21.49%
10 years(CAGR)	N/A	-12.67%
Max(CAGR)	+19.96%	-6.07%

Winner

DRUG

+9.46%

RMAX

-5.52%

DRUG

-19.61%

Winner

RMAX

+41.01%

DRUG

-18.06%

Winner

RMAX

+16.21%

Winner

DRUG

+138.59%

RMAX

+6.81%

5Y(CAGR)

Winner

DRUG

+26.98%

RMAX

-21.49%

10Y(CAGR)

DRUG

N/A

RMAX

-12.67%

Max(CAGR)

Winner

DRUG

+19.96%

RMAX

-6.07%

DRUG vs RMAX - Annual Returns (2013 - 2026)

Returns include dividend reinvestment.

Year	DRUG	RMAX
2026	-14.58%	+25.00%
2025	+89.83%	-26.67%
2024	+1859.10%	-15.59%
2023	-63.33%	-26.98%
2022	-78.04%	-36.49%
2021	-41.30%	-10.39%
2020	N/A	-0.26%
2019	N/A	+25.87%
2018	N/A	-35.34%
2017	N/A	-12.28%
2016	N/A	+55.66%
2015	N/A	+14.50%
2014	N/A	+7.35%
2013	N/A	+18.78%

DRUG vs RMAX Drawdown Comparison

The maximum drawdown for DRUG was -97.68%, occurring on Jul 11, 2024. Recovery took 740 trading sessions.

The maximum drawdown for RMAX was -89.94%, occurring on Apr 1, 2026. This drawdown has not yet recovered.

The current DRUG drawdown is -25.73%. The current RMAX drawdown is -83.56%.

Rank	DRUG	RMAX
#1	-97.68% Nov 8, 2021 - Oct 18, 2024	-89.94% Oct 27, 2017 - Apr 1, 2026
#2	-58.28% Nov 6, 2024 - Sep 29, 2025	-29.16% Nov 11, 2015 - Jul 21, 2016
#3	-38.35% Jan 7, 2026 - Jun 15, 2026	-20.13% Dec 27, 2013 - Nov 21, 2014
#4	-27.84% Mar 22, 2021 - Aug 24, 2021	-16.91% Jan 22, 2015 - Jul 6, 2015
#5	-26.13% Oct 21, 2025 - Nov 28, 2025	-13.71% Oct 4, 2013 - Dec 23, 2013
#6	-19.30% Dec 16, 2025 - Jan 7, 2026	-12.52% Feb 23, 2017 - Aug 4, 2017
#7	-16.21% Sep 30, 2025 - Oct 9, 2025	-12.08% Aug 4, 2015 - Nov 6, 2015
#8	-14.42% Oct 11, 2021 - Nov 3, 2021	-10.97% Dec 5, 2014 - Jan 22, 2015
#9	-9.05% Oct 24, 2024 - Nov 4, 2024	-9.10% Aug 4, 2017 - Oct 4, 2017
#10	-7.65% Oct 14, 2025 - Oct 21, 2025	-6.67% Jul 27, 2016 - Sep 7, 2016
#11	-5.42% Dec 11, 2025 - Dec 16, 2025	-6.40% Oct 24, 2016 - Nov 7, 2016
#12	-4.62% Sep 24, 2021 - Sep 29, 2021	-6.33% Sep 7, 2016 - Sep 22, 2016
#13	-4.59% Dec 8, 2025 - Dec 10, 2025	-6.24% Jan 4, 2017 - Feb 6, 2017
#14	-4.38% Aug 24, 2021 - Sep 1, 2021	-6.00% Sep 22, 2016 - Oct 24, 2016
#15	-3.81% Sep 1, 2021 - Sep 17, 2021	-5.29% Nov 14, 2016 - Nov 25, 2016

Correlation

Correlation between DRUG and RMAX is -0.33 which considered as a weak negative correlation - the stocks show a slight tendency to move in opposite directions.

-0.33

-101